Cargando…

IN-HOSPITAL MORTALITY IN MECHANICALLY VENTILATED PATIENTS WITH COVID-19 WITH DIFFERENT ARDS PHENOTYPES

Detalles Bibliográficos
Autores principales:	LEE, JOOSEOB, CHARKVIANI, MARIAM, FRIEDMAN, HARVEY, RODRIGUEZ-NAVA, GUILLERMO, YANEZ-BELLO, MARIA, TRELLES GARCIA, DANIELA, WON CHUNG, CHUL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Chest Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503217/ http://dx.doi.org/10.1016/j.chest.2021.07.498

Ejemplares similares

THE FIRST AND SECOND WAVES OF THE COVID-19 PANDEMIC IN A COMMUNITY HOSPITAL ICU
por: RODRIGUEZ-NAVA, GUILLERMO, et al.
Publicado: (2021)

EXPERIENCE WITH REMDESIVIR FOR THE TREATMENT OF CRITICAL COVID-19 IN A COMMUNITY-BASED HOSPITAL IN EVANSTON, ILLINOIS
por: EGORYAN, GOAR, et al.
Publicado: (2021)

BIO-MECHANICS OF ARDS IN COVID-19: A PROSPECTIVE OBSERVATIONAL STUDY
por: Naeem, Ehsun, et al.
Publicado: (2020)

OUTCOMES OF WHITE VS MINORITY PATIENTS WITH COVID-19 WITH ARDS TREATED WITH ECMO
por: REDDY, RENUKA, et al.
Publicado: (2021)

ARDS IN CYSTIC FIBROSIS PATIENT WITH DOUBLE LUNG TRANSPLANT SURVIVES SARS-COV-2
por: Modugula, Sujith, et al.
Publicado: (2020)

PULMONARY INFECTIONS IN PATIENTS RECEIVING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) FOR SARS-COV2-RELATED ARDS
por: HALANI, VARUN, et al.
Publicado: (2022)

ENTEROCOCCUS EMPYEMA FOLLOWING EXTRACORPEAL MEMBRANE OXYGENATION (ECMO) FOR COVID-19 ARDS: A CASE REPORT
por: GOERTZEN, STEPHEN M, et al.
Publicado: (2022)

A CASE REPORT OF PNEUMOCYSTIS JIROVECI PNEUMONIA CAUSING ARDS IN HIV/AIDS IN THE SETTING OF COVID-19 PANDEMIC
por: LAMBERT, JOELLA, et al.
Publicado: (2022)

ELDERLY PERSON WITH COVID-19 AND SEVERE ARDS WITH PROLONGED ACTIVE VIRAL REPLICATION AND DOUBLE RESURGENCE OF CYTOKINE STORM TREATED WITH SOTROVIMAB AND CASIRIVIMAB/IMDEVIMAB
por: SIRITHANAKUL, KASEM
Publicado: (2022)

PULMONARY BAROTRAUMA DURING NONINVASIVE VENTILATION IN PATIENTS WITH COVID-19
por: Pattupara, Archana, et al.
Publicado: (2020)

COST ANALYSIS FOR USE OF PROCALCITONIN AND INFLAMMATORY MARKERS IN COVID-19 VENTILATOR-ASSOCIATED PNEUMONIA
por: KIM, A., et al.
Publicado: (2022)

INCREASED RISK OF MECHANICAL VENTILATION AND DEATH IN PATIENTS WITH COVID-19 RECENTLY TREATED WITH RITUXIMAB
por: MILES, B., et al.
Publicado: (2022)

Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2020)

PNEUMOTHORAX IN PATIENTS WITH COVID-19 PNEUMONIA NOT ON POSITIVE PRESSURE VENTILATION: A SYSTEMATIC REVIEW OF CASE REPORTS AND SERIES
por: PATTUPARA, ARCHANA, et al.
Publicado: (2021)

A COMPARISON OF THE INCIDENCE OF VENTILATOR-ASSOCIATED PNEUMONIA AMONG PATIENTS WITH COVID-19 AND INFLUENZA PNEUMONIA A AND B
por: GROSSMAN, J., et al.
Publicado: (2022)

UPFRONT COMMUNITY-ACQUIRED PNEUMONIA ANTIMICROBIAL THERAPY IS ASSOCIATED WITH REDUCED RATES OF VENTILATOR-ASSOCIATED PNEUMONIA IN PATIENTS WITH COVID-19
por: WAKEFIELD, CONNOR, et al.
Publicado: (2022)

EFFECT OF AMANTADINE TREATMENT AND STANDARD OF CARE VS STANDARD OF CARE ON MORTALITY AMONG PATIENTS HOSPITALIZED FOR COVID-19
por: MONTALVAN, ELEAZAR, et al.
Publicado: (2021)

THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19
por: Trelles Garcia, Daniela, et al.
Publicado: (2020)

CLINICAL ATTRIBUTES AND RISK FACTORS FOR MECHANICAL VENTILATION AMONG PATIENTS WITH COVID-19 IN A COMMUNITY HOSPITAL SETTING: A PROPENSITY-MATCHED ANALYSIS
por: SEETHARAM, KARTHIK, et al.
Publicado: (2021)

A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2020)

IDENTIFICATION OF PHENOTYPES AMONG COVID-19 DEATH USING LATENT CLASS ANALYSIS
por: TENG, CATHERINE, et al.
Publicado: (2021)

CLINICAL INDICATORS OF MORTALITY FOR CORONAVIRUS DISEASE 2019 IN AN URBAN HOSPITAL IN BALTIMORE
por: Rapista, Nicole, et al.
Publicado: (2020)

MULTIPLE ORGAN SYSTEMS INVOLVEMENT IN COVID-19 IS ASSOCIATED WITH INCREASED IN MORTALITY
por: LAM, ERIC, et al.
Publicado: (2021)

LONG-TERM MORTALITY IN HOSPITALIZED PATIENTS WITH COVID-19 AND PREEXISTING ASTHMA
por: ARGUETA, FRANKLIN A, et al.
Publicado: (2022)

THE MULBSTA SCORE: PREDICTING RISK OF MORTALITY AND DISEASE SEVERITY IN PATIENTS WITH COVID-19 PNEUMONIA
por: Tusha, Jurgena, et al.
Publicado: (2020)

BASELINE CHARACTERISTICS AND PREDICTORS FOR ALL-CAUSE MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA
por: CHAROENPONG, PRANGTHIP, et al.
Publicado: (2021)

IMPACT OF DEMENTIA AS AN EARLY MORTALITY RISK FACTOR AMONG DECEASED PATIENTS WITH COVID-19
por: RUIZ, CARLOS A PEREZ, et al.
Publicado: (2022)

Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

PREDICTOR VARIABLES FOR MORTALITY IN THE 48 HOURS PRIOR TO ENDOTRACHEAL INTUBATION IN PATIENTS WITH COVID-19 PNEUMONIA
por: SHER, NEHAN, et al.
Publicado: (2021)

COVID-19 VARIANTS AMONG US? PATIENT WITH COVID-19 CLINICAL PHENOTYPE, NEGATIVE RT-PCR TESTING, BUT POSITIVE IGM ANTIBODIES
por: REDDY, RENUKA, et al.
Publicado: (2021)

BASELINE CHARACTERISTICS AND MORTALITY IN PATIENTS WITH SARS-COV-2 CONFIRMED INFECTION: SINGLE MAJOR ACADEMIC CENTER EXPERIENCE
por: Uribe, Juan Pablo, et al.
Publicado: (2020)

IMPACT OF ADMISSION TROPONIN AND TROPONIN RISE DURING HOSPITALIZATION ON MORTALITY IN COVID-19 PNEUMONIA WITH ACUTE RESPIRATORY FAILURE
por: GUPTA, MANASVI, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS AND RISK FACTORS OF MORTALITY FOR HOSPITALIZED PATIENTS WITH CANCER WITH COVID-19 INFECTION IN MACCA, SAUDI ARABIA
por: GHALEB, N., et al.
Publicado: (2022)

MORTALITY COMPARISON IN TWO WAVES OF COVID-19: A COMPARATIVE ANALYSIS OF A TERTIARY CARE HOSPITAL IN INDIA
por: VIG, S., et al.
Publicado: (2022)

THE ROLE OF ASCORBIC ACID IN REDUCING MORTALITY IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: KHOKHER, WALEED, et al.
Publicado: (2021)

EFFECT OF A MULTIDISCIPLINARY FOLLOW-UP PROGRAM ON LONG-TERM, ALL-CAUSE MORTALITY IN VETERAN SURVIVORS OF COVID-19
por: AUNG, YE, et al.
Publicado: (2022)

RISK FACTORS FOR IN-HOSPITAL MORTALITY AMONG ADULTS HOSPITALIZED WITH COVID-19: A CROSS-SECTIONAL STUDY FROM JORDAN
por: AL-MISTAREHI, ABDEL-HAMEED, et al.
Publicado: (2022)

COMPARISON OF SIRS CRITERIA, QSOFA SCORE, AND A COMBINATION OF BOTH FOR THE DIAGNOSIS OF SEPSIS AND PREDICTION OF MORTALITY IN HOSPITALIZED ADULT PATIENTS WITH COVID-19
por: XUE, JUNFENG, et al.
Publicado: (2021)

SIGNIFICANT REDUCTION IN MORTALITY RATE IN CRITICALLY ILL PATIENTS WITH COVID-19 WITH THE IMPLEMENTATION OF A TREATMENT PROTOCOL-EXPERIENCE OF A TERTIARY CARE CENTER IN MIDWESTERN UNITED STATES DURING THE FIRST PEAK OF THE COVID-19 PANDEMIC
por: GUPTA, SANDEEP, et al.
Publicado: (2021)

61. Using Machine Learning for Prediction of Poor Clinical Outcomes in Adult Patients Hospitalized with COVID-19
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iq82kjp24osf47140p7vnci4sp